• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

获得性中枢神经系统脱髓鞘综合征在多民族儿童队列中的发病率。

Incidence of acquired CNS demyelinating syndromes in a multiethnic cohort of children.

机构信息

100 S. Los Robles, Second Floor, Pasadena, CA 91101, USA.

出版信息

Neurology. 2011 Sep 20;77(12):1143-8. doi: 10.1212/WNL.0b013e31822facdd. Epub 2011 Aug 24.

DOI:10.1212/WNL.0b013e31822facdd
PMID:21865580
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3265045/
Abstract

OBJECTIVE

To determine whether the incidence and clinical features of pediatric multiple sclerosis (MS) and other forms of pediatric acquired demyelinating syndromes (ADS) vary by race/ethnicity in a population-based cohort.

METHODS

We used a combination of electronic database searches followed by complete medical records review to identify all children diagnosed with MS and ADS in the multiethnic membership of Kaiser Permanente Southern California from January 1, 2004, to December 31, 2009. Incidence rates were standardized to the US census by age and gender.

RESULTS

We identified 81 incident cases of ADS from 4.87 million person-years of observation in children 0-18 years of age. The incidence rate of pediatric MS was 0.51 per 100,000 person-years (95% confidence interval [CI] 0.33-0.75) and incidence of other forms of ADS including optic neuritis, transverse myelitis, other forms of clinically isolated syndrome (CIS), and acute disseminated encephalomyelitis (ADEM) was 1.56 (95% CI 1.23-1.95) for an overall incidence of ADS of 1.66 per 100,000 person-years (95% CI 1.32-2.06). Incidence of ADS was higher in black (4.4 per 100,000 person-years, 95% CI 2.5-7.2, p < 0.001) and Asian/Pacific Islander (2.8, 95% CI 1.2-5.2, p = 0.02) than white (1.03, 95% CI 0.6-1.7) and Hispanic (1.5, 95% CI 1.1-2.1, per 100,000 person-years) children. Black children were also significantly more likely to have MS than white children (p = 0.001). Children who presented with ADEM were significantly younger than children with other types of ADS clinical presentations (mean age 5.6, range 0.7-17.6 years vs 14.6, range 2.7-18.5, respectively).

CONCLUSIONS

The incidence of pediatric acquired demyelinating syndromes is 1.66 per 100,000 person-years in a population-based cohort of Southern Californian children. The incidence of ADS and MS is higher in black children compared with white and Hispanic children.

摘要

目的

在一个基于人群的队列中,确定儿科多发性硬化症(MS)和其他形式的儿科获得性脱髓鞘综合征(ADS)的发病率和临床特征是否因种族/民族而异。

方法

我们使用电子数据库搜索结合完整的病历回顾,以确定 2004 年 1 月 1 日至 2009 年 12 月 31 日期间在凯撒永久南加州的多种族成员中诊断为 MS 和 ADS 的所有儿童。发病率按年龄和性别标准化为美国人口普查。

结果

我们在 0-18 岁儿童的 487 万人年观察中发现了 81 例 ADS 新发病例。儿科 MS 的发病率为 0.51/10 万人年(95%置信区间 [CI] 0.33-0.75),视神经炎、横贯性脊髓炎、其他形式的临床孤立综合征(CIS)和急性播散性脑脊髓炎(ADEM)等其他形式的 ADS 的发病率为 1.56/10 万人年(95%CI 1.23-1.95),ADS 的总发病率为 1.66/10 万人年(95%CI 1.32-2.06)。黑人(4.4/10 万人年,95%CI 2.5-7.2,p<0.001)和亚裔/太平洋岛民(2.8,95%CI 1.2-5.2,p=0.02)儿童的 ADS 发病率高于白人(1.03,95%CI 0.6-1.7)和西班牙裔(1.5,95%CI 1.1-2.1,每 10 万人年)。黑人儿童患 MS 的可能性也明显高于白人儿童(p=0.001)。患有 ADEM 的儿童明显比患有其他类型 ADS 临床表现的儿童年轻(平均年龄 5.6 岁,范围 0.7-17.6 岁 vs 14.6 岁,范围 2.7-18.5 岁)。

结论

在南加州儿童的基于人群的队列中,儿科获得性脱髓鞘综合征的发病率为每 10 万人年 1.66 例。黑人儿童的 ADS 和 MS 发病率高于白人儿童和西班牙裔儿童。

相似文献

1
Incidence of acquired CNS demyelinating syndromes in a multiethnic cohort of children.获得性中枢神经系统脱髓鞘综合征在多民族儿童队列中的发病率。
Neurology. 2011 Sep 20;77(12):1143-8. doi: 10.1212/WNL.0b013e31822facdd. Epub 2011 Aug 24.
2
Incidence of acquired demyelination of the CNS in Canadian children.加拿大儿童中枢神经系统获得性脱髓鞘疾病的发病率。
Neurology. 2009 Jan 20;72(3):232-9. doi: 10.1212/01.wnl.0000339482.84392.bd.
3
Acute Demyelinating Syndromes: A report of child neurology department of Sfax University Hospital.急性脱髓鞘综合征:来自斯法克斯大学医院儿童神经科的报告。
Mult Scler Relat Disord. 2021 Nov;56:103291. doi: 10.1016/j.msard.2021.103291. Epub 2021 Sep 28.
4
Pediatric acquired demyelinating syndrome (ADS) in inpatient hospital settings: The hospitalization rate, costs, and outcomes in the US.美国住院环境中儿童获得性脱髓鞘综合征(ADS):住院率、费用和结局。
Mult Scler Relat Disord. 2019 Sep;34:150-157. doi: 10.1016/j.msard.2019.06.031. Epub 2019 Jun 27.
5
Paediatric acquired demyelinating syndromes: incidence, clinical and magnetic resonance imaging features.小儿获得性脱髓鞘综合征:发病率、临床和磁共振成像特征。
Mult Scler. 2013 Jan;19(1):76-86. doi: 10.1177/1352458512445944. Epub 2012 Apr 19.
6
The incidence of clinically isolated syndrome in a multi-ethnic cohort.多民族队列中临床孤立综合征的发病率。
J Neurol. 2014 Jul;261(7):1349-55. doi: 10.1007/s00415-014-7349-0. Epub 2014 Apr 29.
7
Anti-MOG antibodies plead against MS diagnosis in an Acquired Demyelinating Syndromes cohort.在获得性脱髓鞘综合征队列中,抗髓鞘少突胶质细胞糖蛋白(MOG)抗体不支持多发性硬化症(MS)的诊断。
Mult Scler. 2015 Oct;21(12):1513-20. doi: 10.1177/1352458514566666. Epub 2015 Feb 6.
8
Nationwide Incidence of Acquired Central Nervous System Demyelination in Icelandic Children.冰岛儿童获得性中枢神经系统脱髓鞘疾病的全国发病率。
Pediatr Neurol. 2015 Dec;53(6):503-7. doi: 10.1016/j.pediatrneurol.2015.08.020. Epub 2015 Sep 5.
9
A nationwide survey of pediatric acquired demyelinating syndromes in Japan.日本全国范围内小儿获得性脱髓鞘综合征调查。
Neurology. 2016 Nov 8;87(19):2006-2015. doi: 10.1212/WNL.0000000000003318. Epub 2016 Oct 14.
10
Evaluation of inflammatory acquired demyelinating syndromes in children: a single-center experience.儿童炎性获得性脱髓鞘综合征的评估:单中心经验
Acta Neurol Belg. 2022 Dec;122(6):1485-1491. doi: 10.1007/s13760-021-01703-4. Epub 2021 May 10.

引用本文的文献

1
Primary Progressive Multiple Sclerosis: New Therapeutic Approaches.原发性进行性多发性硬化症:新的治疗方法
Neuropsychopharmacol Rep. 2025 Sep;45(3):e70039. doi: 10.1002/npr2.70039.
2
Pediatric cerebrospinal fluid immune profiling distinguishes pediatric-onset multiple sclerosis from other pediatric-onset acute neurological disorders.小儿脑脊液免疫谱分析可将小儿多发性硬化症与其他小儿急性神经系统疾病区分开来。
bioRxiv. 2025 Mar 1:2025.02.27.637541. doi: 10.1101/2025.02.27.637541.
3
Pediatric Neuroimaging of Multiple Sclerosis and Neuroinflammatory Diseases.小儿多发性硬化症和神经炎性疾病的神经影像学
Tomography. 2024 Dec 20;10(12):2100-2127. doi: 10.3390/tomography10120149.
4
Management and outcomes of pediatric optic neuritis in a tertiary hospital in Riyadh, Saudi Arabia: a retrospective study.沙特阿拉伯利雅得一家三级医院小儿视神经炎的管理与治疗结果:一项回顾性研究。
BMC Neurol. 2024 Dec 5;24(1):474. doi: 10.1186/s12883-024-03982-9.
5
Protocol on establishing a national disease registry-Swiss Pediatric Inflammatory Brain Disease Registry.建立国家疾病登记册的方案-瑞士儿科炎症性脑疾病登记册。
PLoS One. 2024 Apr 16;19(4):e0290908. doi: 10.1371/journal.pone.0290908. eCollection 2024.
6
Myelin insults differentials on MRI in children: In the light of an ADEM case.儿童MRI上的髓鞘损伤差异:基于一例急性播散性脑脊髓炎病例
Radiol Case Rep. 2023 Nov 10;19(1):408-413. doi: 10.1016/j.radcr.2023.08.107. eCollection 2024 Jan.
7
Juvenile multiple sclerosis: addressing epidemiology, diagnosis, therapeutic, and prognostic updates along with cognitive dysfunction and quality of life.青少年多发性硬化症:探讨流行病学、诊断、治疗及预后的最新进展,以及认知功能障碍和生活质量。
Ann Med Surg (Lond). 2023 May 25;85(9):4433-4441. doi: 10.1097/MS9.0000000000000930. eCollection 2023 Sep.
8
Clinical and Epidemiological Findings of Pediatric Onset Multiple Sclerosis in East-Azerbaijan, Iran; A Population-based Study.伊朗东阿塞拜疆省儿童期多发性硬化症的临床和流行病学研究结果;一项基于人群的研究
Iran J Child Neurol. 2023 Summer;17(3):109-119. doi: 10.22037/ijcn.v17i2.34417. Epub 2023 Jul 1.
9
Early blood neurofilament light chain and myelin oligodendrocyte glycoprotein antibody levels associate with different disease courses of myelin oligodendrocyte glycoprotein-associated disease in children.早期血神经丝轻链和髓鞘少突胶质细胞糖蛋白抗体水平与儿童髓鞘少突胶质细胞糖蛋白相关疾病的不同病程相关。
Brain Commun. 2023 Mar 15;5(2):fcad063. doi: 10.1093/braincomms/fcad063. eCollection 2023.
10
Characteristics of Optic Neuritis in South Korean Children and Adolescents: A Retrospective Multicenter Study.韩国儿童和青少年视神经炎的特征:一项回顾性多中心研究。
J Ophthalmol. 2022 Sep 7;2022:4281772. doi: 10.1155/2022/4281772. eCollection 2022.

本文引用的文献

1
Health plan administrative records versus birth certificate records: quality of race and ethnicity information in children.健康计划管理记录与出生证明记录:儿童种族和族裔信息的质量。
BMC Health Serv Res. 2010 Nov 23;10:316. doi: 10.1186/1472-6963-10-316.
2
Relapsing demyelinating CNS disease in a Korean pediatric population: multiple sclerosis versus neuromyelitis optica.韩国儿科人群中的复发性脱髓鞘中枢神经系统疾病:多发性硬化症与视神经脊髓炎。
Mult Scler. 2011 Jan;17(1):67-73. doi: 10.1177/1352458510382685. Epub 2010 Sep 21.
3
Vitamin D status is associated with relapse rate in pediatric-onset multiple sclerosis.维生素 D 状态与儿童发病多发性硬化症的复发率相关。
Ann Neurol. 2010 May;67(5):618-24. doi: 10.1002/ana.21972.
4
A comparison of MRI criteria for diagnosing pediatric ADEM and MS.儿童 ADEM 和 MS 的 MRI 诊断标准比较。
Neurology. 2010 May 4;74(18):1412-5. doi: 10.1212/WNL.0b013e3181dc138b. Epub 2010 Mar 24.
5
Prevalence of extreme obesity in a multiethnic cohort of children and adolescents.多民族队列儿童和青少年极端肥胖症的患病率。
J Pediatr. 2010 Jul;157(1):26-31.e2. doi: 10.1016/j.jpeds.2010.01.025. Epub 2010 Mar 19.
6
Expression of the multiple sclerosis-associated MHC class II Allele HLA-DRB1*1501 is regulated by vitamin D.与多发性硬化症相关的MHC II类等位基因HLA - DRB1*1501的表达受维生素D调控。
PLoS Genet. 2009 Feb;5(2):e1000369. doi: 10.1371/journal.pgen.1000369. Epub 2009 Feb 6.
7
Incidence of acquired demyelination of the CNS in Canadian children.加拿大儿童中枢神经系统获得性脱髓鞘疾病的发病率。
Neurology. 2009 Jan 20;72(3):232-9. doi: 10.1212/01.wnl.0000339482.84392.bd.
8
Assessing the vitamin D status of the US population.评估美国人群的维生素D状况。
Am J Clin Nutr. 2008 Aug;88(2):558S-564S. doi: 10.1093/ajcn/88.2.558S.
9
An approach to the diagnosis of acute transverse myelitis.急性横贯性脊髓炎的诊断方法。
Semin Neurol. 2008 Feb;28(1):105-20. doi: 10.1055/s-2007-1019132.
10
Clinical features and viral serologies in children with multiple sclerosis: a multinational observational study.多发性硬化症患儿的临床特征与病毒血清学:一项多国观察性研究。
Lancet Neurol. 2007 Sep;6(9):773-81. doi: 10.1016/S1474-4422(07)70196-5.